Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues

JM Bronstein, M Tagliati, RL Alterman… - Archives of …, 2011 - jamanetwork.com
Objective: To provide recommendations to patients, physicians, and other health care
providers on several issues involving deep brain stimulation (DBS) for Parkinson disease …

An update on best practice of deep brain stimulation in Parkinson's disease

CJ Hartmann, S Fliegen, SJ Groiss… - Therapeutic …, 2019 - journals.sagepub.com
During the last 30 years, deep brain stimulation (DBS) has evolved into the clinical standard
of care as a highly effective treatment for advanced Parkinson's disease. Careful patient …

Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial

VJJ Odekerken, T van Laar, MJ Staal, A Mosch… - The Lancet …, 2013 - thelancet.com
Summary Background Patients with advanced Parkinson's disease often have rapid swings
between mobility and immobility, and many respond unsatisfactorily to adjustments in …

[HTML][HTML] Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease

KA Follett, FM Weaver, M Stern, K Hur… - … England Journal of …, 2010 - Mass Medical Soc
Background Deep-brain stimulation is the surgical procedure of choice for patients with
advanced Parkinson's disease. The globus pallidus interna and the subthalamic nucleus are …

Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes

FM Weaver, KA Follett, M Stern, P Luo, CL Harris… - Neurology, 2012 - AAN Enterprises
Objectives: Our objective was to compare long-term outcomes of deep brain stimulation
(DBS) of the globus pallidus interna (GPi) and subthalamic nucleus (STN) for patients with …

Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial

MS Okun, BV Gallo, G Mandybur, J Jagid… - The Lancet …, 2012 - thelancet.com
Background The effects of constant-current deep brain stimulation (DBS) have not been
studied in controlled trials in patients with Parkinson's disease. We aimed to assess the …

Health‐related quality‐of‐life scales in Parkinson's disease: critique and recommendations

P Martinez‐Martin, M Jeukens‐Visser… - Movement …, 2011 - Wiley Online Library
Health‐related quality of life is an important patient‐reported outcome used in intervention
trials and for monitoring the consequences of health status on physical, mental, and social …

Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa

Y Smith, T Wichmann, SA Factor… - …, 2012 - nature.com
The demonstration that dopamine loss is the key pathological feature of Parkinson's disease
(PD), and the subsequent introduction of levodopa have revolutionalized the field of PD …

[HTML][HTML] Deep brain stimulation for movement disorders of basal ganglia origin: restoring function or functionality?

T Wichmann, MR DeLong - Neurotherapeutics, 2016 - Elsevier
Deep brain stimulation (DBS) is highly effective for both hypo-and hyperkinetic movement
disorders of basal ganglia origin. The clinical use of DBS is, in part, empiric, based on the …

Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up

A Mansouri, S Taslimi, JH Badhiwala, CD Witiw… - Journal of …, 2018 - thejns.org
OBJECTIVE Deep brain stimulation (DBS) is effective in the management of patients with
advanced Parkinson's disease (PD). While both the globus pallidus pars interna (GPi) and …